Entera Bio Ltd. Made Headway
Thu, Jul 21, 2022 at 07:08 PM
Entera Bio Ltd. (ENTX:NASDAQ) rocketted at $1.89, a gain of 25.2%. On Thu, Jul 21, 2022, ENTX:NASDAQ touched a New 2-Week High of $1.89. The stock appeared on our News Catalysts scanner on Mon, Jul 18, 2022 at 08:41 AM in the 'BIOTECH' category. From Thu, Jul 07, 2022, the stock recorded 60.00% Up Days and 27.27% Green Days
About Entera Bio Ltd. (ENTX:NASDAQ)
Entera Bio Ltd is a biotechnology company specializing in the oral delivery of large molecules and biologics. It conducts clinical trials on its proprietary technology which allows oral delivery of large molecules and biologics.
Top 10 Gainers:
- Addex Therapeutics Ltd (ADXN:NASDAQ), 110.4%
- 1Life Healthcare, Inc. (ONEM:NASDAQ), 69.45%
- Tabula Rasa HealthCare, Inc. (TRHC:NASDAQ), 56.54%
- ToughBuilt Industries, Inc. (TBLT:NASDAQ), 36.52%
- Vertical Aerospace Ltd. (EVTL:NYSE), 34.28%
- Skylight Health Group Inc. (SLHG:NASDAQ), 26.45%
- Entera Bio Ltd. (ENTX:NASDAQ), 25.17%
- Pintec Technology Holdings Limited (PT:NASDAQ), 25.1%
- MoonLake Immunotherapeutics Com (MLTX:NASDAQ), 24.95%
- Phunware, Inc. (PHUN:NASDAQ), 24.82%